FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to dermatology, and concerns treating atopic dermatitis in children with probiotic preparations. That is ensured by microbiological examination of faeces, performing type identification of all recovered cultures of microorganisms by MALDI-TOF mass spectrometry. Thereafter, the probiotic is selected in accordance with a deficiency or excess in the patient of representatives of specific microorganisms of normal microflora.
EFFECT: method provides reduced length of treatment and prolonged clinical remission ensured by individual selection of the probiotic preparation.
1 cl, 4 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTING SEVERITY OF ATOPIC DERMATITIS IN CHILDREN WITH ACCOMPANYING INTESTINAL DYSBACTERIOSIS | 2018 |
|
RU2692803C1 |
METHOD OF PREVENTING ATOPIC DERMATITIS IN INFANTS BY MODULATING MICROBIAL MECHANISM OF HISTAMINE FORMATION | 2017 |
|
RU2665173C1 |
COMPOSITION COMPRISING PROBIOTIC BACTERIA FOR USE IN TREATING IMMUNE DISORDERS | 2011 |
|
RU2712751C2 |
COMPOSITION, CONTAINING PROBIOTIC BACTERIA FOR USE IN TREATING IMMUNE DISORDERS | 2011 |
|
RU2605293C2 |
METHOD FOR TREATING ALLERGIES | 2008 |
|
RU2367453C1 |
CURATIVE-PROPHYLACTIC BIOPREPARATION BASED ON DRY BIOMASS OF BIFIDUM BACTERIA AND LACTIC ACID BACTERIA, BIOLOGICALLY ACTIVE FOOD SUPPLEMENT BASED ON DRY BIOMASS OF BIFIDUM BACTERIA AND LACTIC ACID BACTERIA, DRY BIOMASS OF BIFIDUM BACTERIA AND LACTIC ACID BACTERIA AND METHOD FOR ITS PREPARING | 2003 |
|
RU2257408C1 |
METHOD FOR TREATMENT OF PATIENTS WITH STAGE V CHRONIC KIDNEY DISEASE AT DIALYSIS STAGE | 2020 |
|
RU2753127C1 |
METHOD FOR RESTORING ONE'S OWN INTESTINAL MICROBIOTA AFTER ANTIBIOTIC THERAPY | 2021 |
|
RU2775887C1 |
MICROORGANISM COMPOSITION (VARIANTS) | 2002 |
|
RU2291899C2 |
USE OF PROBIOTICS IN THE TREATMENT AND/OR PREVENTION OF ATOPIC DERMATITIS | 2017 |
|
RU2757453C2 |
Authors
Dates
2019-10-07—Published
2018-08-09—Filed